Ekaterina Krauss
Giessen, HE 35392, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Post-transplant trajectories of the CRP-to-albumin ratio identify a late-emerging high-risk phenotype in interstitial lung disease.
Journal: BMC pulmonary medicine
Published: June 30, 2026
Beyond Diffusion Capacity: Continuous Exercise Oximetry Reveals Phenotype-Related Cardiopulmonary Signals in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis-A eurILDreg Pilot Study.
Journal: Journal of clinical medicine
Published: June 09, 2026
Tidal Volume in Idiopathic Pulmonary Fibrosis: Restriction Severity and Prognostic Information Beyond Forced Vital Capacity.
Journal: Respiration; international review of thoracic diseases
Published: May 14, 2026
Sex-Dependent Integration of Symptoms and Functional Vulnerability in Interstitial Lung Disease: eurILDreg Study.
Journal: Respiration; international review of thoracic diseases
Published: February 06, 2026
Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry.
Journal: Respiration; international review of thoracic diseases
Published: December 31, 2025
The Patient Journey in Interstitial Lung Disease: Mobility, Independence, and Psychological Burden.
Journal: Journal of clinical medicine
Published: November 12, 2025
Peri-transplant frailty changes impact survival in interstitial lung diseases.
Journal: ERJ open research
Published: November 11, 2025
Pulmonary Hypertension Drives Prognosis in Idiopathic Pulmonary Fibrosis: Insights from the European IPF Registry.
Journal: Journal of clinical medicine
Published: September 02, 2025
Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis.
Journal: Signal transduction and targeted therapy
Published: August 22, 2025
Dual Impacts of Lung Transplantation on the Recovery and Comorbidity of Interstitial Lung Diseases: A Longitudinal Assessment of the Benefits and Burden.
Journal: Journal of clinical medicine
Published: July 27, 2025
RAAS antagonists dampen the SARS-CoV-2 infection in ex-vivo cultured human precision-cut lung slices.
Journal: Respiratory research
Published: May 15, 2025
Last Updated: 09/26/2026